RxDoctor Payments Data

Marie Kenny, DO

Family Medicine · Millington, MINPI 1578130076

Payments from drug & device makers

$590in general payments, 2019–2025

Across 30 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$214
  • Sanofi$94
  • Novo Nordisk$84
  • GSK$60
  • Exact Sciences$38
  • AbbVie$29
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca13$214
Sanofi1$94
Novo Nordisk5$84
GSK4$60
Exact Sciences2$38
AbbVie1$29
Pfizer1$20
Merck1$17
Lilly USA, LLC1$17
Amgen1$17

How this compares

$590 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$30,544
Medicare patients
133
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$61,974
EliquisApixaban18$23,980
JardianceEmpagliflozin13$17,186
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$15,568
XareltoRivaroxaban15$11,293
Atorvastatin Calcium147$2,151
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,948
Losartan Potassium89$1,195
Omeprazole77$1,154
Pravastatin Sodium48$1,100
Rosuvastatin Calcium46$1,085
Levothyroxine Sodium99$1,007
Montelukast Sodium50$1,005
Nifedipine ErNifedipine24$827
Lisinopril85$797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$84$61,97442 claims
PfizerEliquis$20$23,98018 claims
GSKTrelegy Ellipta$60$15,56816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Millington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →